Genesee Capital Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,376
| Closed | -$716K | – | 130 |
|
|
2024
Q3 | $716K | Sell |
1,376
-18
| -1% | -$9.36K | 0.34% | 62 |
|
|
2024
Q2 | $755K | Sell |
1,394
-320
| -19% | -$173K | 0.37% | 61 |
|
|
2024
Q1 | $889K | Buy |
1,714
+18
| +1% | +$9.33K | 0.49% | 48 |
|
|
2023
Q4 | $800K | Buy |
1,696
+135
| +9% | +$63.6K | 0.49% | 46 |
|
|
2023
Q3 | $680K | Sell |
1,561
-75
| -5% | -$32.7K | 0.49% | 52 |
|
|
2023
Q2 | $727K | Sell |
1,636
-1,285
| -44% | -$571K | 0.5% | 51 |
|
|
2023
Q1 | $1.34M | Buy |
2,921
+4
| +0.1% | +$1.84K | 0.95% | 26 |
|
|
2022
Q4 | $1.5M | Sell |
2,917
-208
| -7% | -$107K | 1.11% | 25 |
|
|
2022
Q3 | $1.42M | Sell |
3,125
-32
| -1% | -$14.5K | 1.08% | 26 |
|
|
2022
Q2 | $1.52M | Buy |
+3,157
| New | +$1.52M | 1.06% | 26 |
|